Background/Aims: The aim of this study was to investigate the role of microRNA miR-761 in the progression and metastasis of non-small cell lung cancer (NSCLC), and the mechanisms by which miR-761 regulates cell proliferation and metastatic activity of NSCLC cell lines. Methods: Quantitative real-time PCR (qRT-PCR) was used to assess miR-761 expression in NSCLC serum and tissue. MTT, wound healing, and transwell assays were performed to examine the role of miR-761 in regulation of cell proliferation and metastatic activity in NSCLC cell lines. In addition, the correlations of miR-761 expression with clinical-pathologic factors were statistically analyzed. Finally, we investigated whether miR-761 promotes proliferation and metastasis in NSCLC cell lines by targeting ING4 (inhibitor of growth family, member 4) and TIMP2 (tissue inhibitor of metalloproteinase 2). Results: MiR-761 was significantly upregulated in both NSCLC serum and tissues as compared to normal participants and paired noncancerous tissues respectively. Ectopic expression of miR-761 promoted cell proliferation and metastasis in H460 cells, while miR-761 inhibitor reduced proliferation rates and metastasis in H23 cells. Furthermore, luciferase reporter assay and functional analyses indicated that miR-761 directly targeted ING4 and TIMP2. Conclusion: miR-761 promotes progression and metastasis of NSCLC by targeting ING4 and TIMP2.
Introduction
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all cases of lung cancer, the leading cause of cancer-related mortality worldwide [1, 2] . Lung cancer amplified from MRC5 cells by PCR and constructed in a pMIR luciferase reporter (Promega, Madison, WI, USA). The ING4 and TIMP2 gene without 3'UTR region was PCR-amplified from MRC5 cells and inserted to pcDNA3.1 vector (Promega). Lipofectamine® 2000 was used for plasmid transfection (Life Technologies). Luciferase activity was measured 48 h posttransfection, using a dual luciferase reporter system (Promega) according to the manufacturer's protocol and normalized to the corresponding Renilla luciferase activity.
Quantitative real-time PCR (qPCR)
Total RNA was isolated using Trizol reagent (Life Technologies, Carlsbad, CA, USA) according to the manufacturer's recommendations. The expression levels of miR-761 were quantified using the miRNAspecific TaqMan MiRNA Assay Kit (Applied Biosystems, Foster City, CA, USA), and normalized with U6 small nuclear RNA. Total RNA (1 μg) was subjected to reverse transcription with the SuperScript III RT PCR kit (Life Technologies). cDNA was applied to real-time PCR amplification with SYBR Green for ING4 and TIMP2 mRNA detection. β-actin was used as an internal control. The sequences for qRT-PCR primers were as follows:
ING4 sense primer (5'-CAAGGAATTTGGTGACGACAAG-3') and antisense primer (5'-TCCAGCCGCCGAATGT-3'); TIMP2 sense primer (5'-GTCATCTTGATCTCATAACGCTGG-3') and antisense primer (5'-AGCCCATCTGTACCTGTGGTTCA-3'); β-actin sense primer (5′-CAGGGAGTGATGGTGGGCA-3′) and antisense primer (5′-CAAACATCATCTGGTCATCTTCTC-3′).
MTT assay
MTT assay was performed as previously described [16] , briefly, cells (2.5×10
3 ) were seeded into 96-well plates in growing medium and allowed to adhere overnight. MTT solution (20 μL; Promega) was added into medium at each time point and incubated for an additional 3 h at 37°C in the dark. OD values were measured at 450nm.
BrdU assay
Transfected cells were grown on 4-well chamber slides for 2 days. Medium containing BrdU (10 µmol/L) (Sigma, St. Louis, MO, USA) was added to each well and incubated at 37°C for 1 h. Cells were washed and fixed using 4% paraformaldehyde. Cells were then incubated with anti-BrdU antibody overnight at 4°C after blocking. Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (Dako, Carpintera, CA, USA) was used to detect BrdU incorporation. Cells were visualized under an Olympus fluorescence microscope (Olympus, Tokyo, Japan).
Wound healing assay Treated cells (1×10

6
) were initially seeded uniformly onto six-well plates and cultured overnight. An artificial homogenous "wound" was carefully created at 0 h, using a sterile plastic 200 pipette tip to scratch the confluent cell monolayer. After wounding, the debris was removed by washing the cells with medium. Cells that migrated into the wounded area or cells were photographed and measured at 0 and 36 h.
Transwell assay
Invasion of NSCLC cells was determined using Matrigel invasion chambers with 8-µm porous membranes (BD Biosciences, San Jose, CA, USA). Transfected cells (2 × 10 5 ) were plated into the upper chamber in 100 μL of basal medium with 0.1% FBS. The lower chamber was filled with 400 μL basal medium with 10% FBS in 24-well plates. After 24 h, uninvaded cells in the inserts were removed with cotton swabs. The invaded cells on the bottom of the membrane were fixed and stained with 0.1% crystal violet. The numbers of invaded cells were counted.
Western blot
Cells were washed with cold PBS and lysed with RIPA buffer with protease inhibitor. Cell lysates were centrifuged at 12,000 rpm for 15 min at 4°C, and supernatants were collected. Protein concentrations were measured using the BCA kit (Pierce, Rockford, IL, USA), and equal amounts of total protein were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to polyvinylidene Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry difluoride membranes (PVDF, Bio-Rad, Hercules, CA, USA), which were blocked with 5% skimmed milk in TBS containing 0.1% Tween-20 (TBST), followed by incubation with primary antibodies overnight at 4°C. After rinsing, membranes were incubated with secondary antibodies for 2 h at room temperature. Antibodies against ING4, TIMP2, and β-actin were all purchased from Santa Cruz Biotechnology.
Statistical analysis
Each experiment was performed at least three times. Statistical analysis was performed with SPSS 16.0 for Windows (SPSS, Chicago, IL, USA). The data were plotted as mean ± SD. One-way Anova was used for group comparisons. Pearson's chi-square test was used for clinical characteristic comparisons. A P value of <0.05 was considered statistically significant. All images were captured and measured, using Image J software.
Results
MiR-761 is overexpressed in NSCLC patients' serum, NSCLC tissues and cell lines
To investigate the role of miR-761 in human NSCLC, we first searched the public database for miR-761 expression in NSCLC patient samples and healthy controls. Analysis using database NCBI/GEO/GSE40738 [17] showed that miR-761 was significantly overexpressed in NSCLC patient serum samples (Fig. 1A , p < 0.01). This result was further confirmed by examining 33 NSCLC patient serum samples and serum from 33 normal participants from our hospital (Fig. 1B) . Next, qPCR was performed to analyze miR-761 expression in NSCLC tissues, then compared them with those in adjacent normal lung tissue. Results showed that miR-761 was significantly overexpressed in NSCLC tissues (Fig. 1C) . Furthermore, 
compared to normal diploid human lung fibroblast cell line, MRC5 (Fig. 1D ). We selected a miR-761 high-expression cell line, H23, and low-expression cell line, H460, for further experiments.
MiR-761 promotes NSCLC cell proliferation, migration and invasion
To evaluate the role of miR-761 in NSCLC development, we transiently transfected miR-761 or miR-761 inhibitor (antimiR-761) into H460 or H23 NSCLC cells, respectively ( Fig. 2A) . In the H460 cell line, MTT assay results revealed a significant increase in cell proliferation when miR-761 was overexpressed, while inhibition of miR-761 expression in H23 cells led to significantly reduced cell proliferation (Fig. 2B) . BrdU assays further confirmed these results. More BrdU-positive cells were observed in response to ectopic expression of miR-761 in H460 cells (Fig. 2C) . We next examined the effects of miR-761 on NSCLC cell migration and invasion ability. The wound healing assay revealed that upregulation of miR-761 induced faster closing of scratch wounds in H460 cells, and inhibition of miR-761 resulted in slower closing of scratch wounds in H23 cells (Fig. 3A) . Similarly, in transwell invasion assays, overexpression of miR-761 remarkably enhanced invasion of H460 cells. Likewise, antimiR-761 significantly inhibited the invasion of H23 cells (Fig. 3B) . Moreover, we found high expression of miR-761 was correlated with lymphatic metastasis in NSCLC patient samples (Table 1) . These results indicate that miR-761 regulates the proliferation, migration and invasion of NSCLC.
MiR-761 directly targets ING4 and TIMP2
To investigate the mechanisms by which miR-761 mediates increases in NSCLC cell proliferation and motility, we used TargetScan algorithm and resources from microRNA.org and found ING4 and TIMP2 are potential targets of miR-761 (Fig. 4A) . We inserted WT (wild type) or MU (mutant) 3'UTRs of ING4 and TIMP2 downstream of the luciferase reporter 
MiR-761 regulates NSCLC cell proliferation and metastasis via ING4 and TIMP2
It has been reported that ING4 and TIMP2 play negative roles in lung cancer development [18, 19] . To further confirm their functions in NSCLC cell lines, specific siRNAs were used to knock down ING4 and TIMP2 in H460 cells. Similar to overexpression of miR-761 in H460 cells, depletion of ING4 or TIMP2 significantly stimulated cell proliferation, migration, and invasion ability (Fig. 6A-H) . To investigate whether the role of miR-761 in tumor promotion is mediated by ING4 and TIMP2, we co-overexpressed ING4 and/or TIMP2 with miR-761 in H460 cells (Fig. 7A) . MTT, wound healing, and transwell assays were subsequently performed. As showed in Fig. 7B-D, overexpression of ING4 or TIMP2 abrogated the enhancement effects of miR-761 in NSCLC cell proliferation, migration and invasion, at least in part. Moreover, when both ING4 and TIMP2 were overexpressed at the same time, no significant differences were observed between control cells and the cells that ectopically expressed miR-761 (Fig.  7B-D) . These results suggested that miR-761 plays a role in proliferation and metastasis of NSCLC by targeting ING4 and TIMP2.
Discussion
Despite decades of progress in treatment of lung cancer, the five-year survival rate of lung cancer remains approximately 15.7% [2, 20] . According to the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database, the survival rates of NSCLC patients vary dramatically according to the stages at which NSCLC is diagnosed [21] . However, NSCLC is often insidious, causing no symptoms until the disease is well advanced [22, 23] . About 70% of patients with lung cancer already have metastatic disease at the time of diagnosis [5] . Hence, there is a high demand for biomarkers that predict NSCLC progression and can be targeted for treating NSCLC.
In the present study, we found that miR-761 is significantly upregulated in NSCLC tissues as compared to paired adjacent normal lung tissue. Compared to normal control, NSCLC patients' serum with exhibited higher expression of miR-761. High expression of miR- To determine the potential role of miR-761 overexpression in NSCLC, we performed MTT assays and BrdU staining, which showed a higher proliferation rate in H460 cells with ectopic expression of miR-761. Further, the results of the wound healing and transwell assays demonstrated that overexpression of miR-761 enhanced metastatic activity of H460 cells. Conversely, treatment with the miR-761 inhibitor resulted in a decrease in cell proliferation and metastatic activity of H23 cells. These results suggest that miR-761 overexpression could contribute to progression and metastasis of NSCLC. However, in vivo studies are needed to determine the stage at which miR-761 expression starts to rise, as well as the role of miR-761 during development of NSCLC. We also need a better understanding of the effects of miR-761 on NSCLC cells, such as anti-apoptosis. Jonathan E. Cohen has predicted miR-761 regulates networks of gene important in plasticity, development and tumorigenesis. We first study the biofunctional role of miR-761 in NSCLC.
We identified ING4 and TIMP2 as the direct targets of miR-761. After using the predictive TargetScan algorithm and resources from microRNA.org [25] , luciferase reporter assays were performed, and the results revealed that miR-761 directly bound to the 3'UTR in the mRNA of ING4 and TIMP2. Furthermore, functional studies were performed to confirm whether the role of miR-761 is mediated by ING4 and TIMP2. Overexpression of ING4 and TIMP2 consistently reduced cell metastatic activity to the basal level, which was enhanced by ectopic expression of miR-761 in H460 cells. ING4 has been well-established as a tumor suppressor in gliomas, breast tumors, stomach adenocarcinoma, and lung cancers [26] [27] [28] [29] . Wang et al. reported that downregulation of ING4 was associated with initiation and progression of lung cancer [28] . In our study, we confirmed that siRNA-mediated depletion of ING4 significantly increased cell proliferation and metastatic activity in H460 cells. TIMP2 was found to inhibit metastasis by enhancing E-cadherin/beta-catenin complex expression in A549 lung cancer cells [19] . Similar to ING4, depletion of TIMP2 promoted H460 cell proliferation, metastasis and invasion. Additionally, adenovirus-mediated overexpression of ING4 was found to enhance the radiosensitivity of nonsmall cell lung cancer [30] , and to overcome docetaxel resistance in lung adenocarcinoma [31] . Taken together, it seems that inhibition of miR-761 suppresses progression and metastasis of NSCLC, and facilitates docetaxel-based chemotherapies and radiotherapies of NSCLC.
In summary, we found that miR-761 expression was upregulated in NSCLC serum and tissues. Mechanistically, miR-761 promoted cell proliferation, metastasis and invasion by targeting ING4 and TIMP2 in NSCLC cell lines. Our findings indicate that miR-761 may be a biomarker and a target for gene therapies for NSCLC.
